Skip to content

AIM Market Roundup: Rome Resources, Celadon Pharmaceuticals, Churchill China

AIM Market Roundup: Rome Resources, Celadon Pharmaceuticals, Churchill China

A slightly earlier copy time today and the AIM All Share is once again reeling as, like many markets, investors attempt to understand what lies ahead. At 3pm the index was down just over 13 points at 628.61.

  • Rome Resources +27%
  • Celadon Pharmaceuticals +25%
  • Churchill China +10%
  • Ethernity Networks -27%
  • Verici DX -21%

Rome Resources [LON:RMR] topped the board, up 27% by 3pm. There was an industry note out this morning suggesting that military activity in the Democratic Republic of Congo may have subsided to an extent that would allow drilling operations at Bisie to resume, following a close on one month suspension.


Celadon Pharmaceuticals LON:CEL is back on our list with the share price continuing to show elevated levels of volatility. 50% swings are looking normal for now and given the prospect of delisting, this sort of activity may well continue for a while yet.

Churchill China LON:CHH was 10% higher off the back of full year results which highlighted resilience for the business against a challenging commercial backdrop. The gain has recovered the losses accumulated over the last month.

Ethernity Networks LON:ENET was the biggest faller at copy time, off 27%. That’s an extension of yesterday’s losses after management failed to secure shareholder backing for resolutions at the recent EGM but it needs to be noted that volumes were thin and the quoted spread exceeded the loss.

Verici DX LON:VRCI was down 21%. We noted the stock’s poor performance at the start of the week following an update and with Trump now looking at more sector specific tariffs, the company’s exposure to the US market is clearly cause for concern.

Share this article

Invest with these platforms

Hargreaves Lansdown

IG

Interactive Brokers

Interactive Investor

Charles Stanley

IG

Interactive Brokers

Charles Stanley

Looking for great investing ideas? Get our free newsletter.

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
Schroders

aberdeen
WisdomTree
ARK
Plus500
CMC Markets
Back To Top